• Explore /
  • Poster
  • / A phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC).

A phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC).

Abstract Poster

Authors

null

Neil J. Shah

Memorial Sloan Kettering Cancer Center, New York, NY

Neil J. Shah , Matthew T Campbell , Shifeng S. Mao , Moshe Chaim Ornstein , Naomi B. Haas , Xin Gao , Hans J. Hammers , Holavanahalli Keshava-Prasad , Hongxia Yan , Vanessa Esquibel , Robert B. Geller , Katy Beckermann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04300140

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 666)

DOI

10.1200/JCO.2023.41.6_suppl.666

Abstract #

666

Poster Bd #

G17

Abstract Disclosures

Similar Posters

First Author: Katy Beckermann

First Author: Neil J. Shah

First Author: Katy Beckermann

First Author: Andrew Johns